Echosens

I would like more information on FibroScan

To learn more about FibroScan and our family of products please fill out our contact form and speak with a representative!

 

About

 

 


Powered by proprietary VCTE™ and CAP™ technologies, FibroScan® can

simultaneously quantify stiffness of liver tissue and provide an approximation of

fat in the liver. With over 4,500 systems placed worldwide, the FibroScan®

examination has become a standard in many prominent liver disease guidelines,

supporting healthcare practitioners around the world.


FibroScan® is FDA cleared as an aid for the diagnosis and monitoring of adult

patients with liver disease and is supported by over 2,000 independent peer

reviewed publications.

FibroScan® is designed for simplicity and reproducibility


FibroScan® is the reference for non-invasive

assessment of liver disease
across major

treatment guidelines.

 

As your needs to quickly diagnosis and manage patients with liver disease

increase, FibroScan® systems are becoming more portable to provide greater

access for patients.


In addition to FibroScan® 502 Touch and the FibroScan® 530 Compact, we now

offer enhanced portability with FibroScan® 430 mini+, making non-invasive liver

diagnostics accessible to patients- wherever they are.


 

Echosens North America Inc.
950 Winter St
Waltham, MA 02451
www.echosens.us

FibroScan® refers to the family of products manufactured by Echosens™.

Echosens is the innovator in the field of non-invasive assessment of liver disease

at point of care. Our FibroScan® products have been FDA cleared as a tool to

quantitatively diagnose and monitor adult patients with liver disease, as part of an

overall assessment of liver health.

Intended Use / Indications for Use


The FibroScan® Family of Products (Models: 502 Touch, 530 Compact, and 430 Mini+) is

intended to provide 50Hz shear wave speed measurements and estimates of tissue stiffness as

well as 3.5 MHz ultrasound coefficient of attenuation (CAP: Controlled Attenuation Parameter) in

internal structures of the body.
 

FibroScan® Family of Products (Models: 502 Touch, 530 Compact, and 430 Mini+) is indicated

for noninvasive measurement in the liver of 50 Hz shear wave speed and estimates of stiffness

as well as 3.5 MHz ultrasound coefficient of attenuation (CAP: Controlled Attenuation

Parameter).  The shear wave speed and stiffness, and CAP may be used as an aid to diagnosis

and monitoring of adult patients with liver disease, as part of an overall assessment of the liver.
 

Shear wave speed and stiffness may be used as an aid to clinical management of pediatric

patients with liver disease.